中金公司 reported revenue of ¥19.30B for the period ended 2026-06-30, +50.5% year on year. Net income was ¥8.27B, a 42.8% net margin on a 100.0% gross margin. The largest revenue line is 财富管理 at 33% of the total. Free cash flow for the period was ¥37.59B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥19.30B | +50.5% |
| Gross profit | ¥19.30B | — |
| Operating income | ¥10.21B | — |
| Net income | ¥8.27B | +90.8% |
| Gross margin | 100.0% | Net margin 42.8% |
| Revenue Q/Q | +18.7% | — |
| Segment | Revenue | Share |
|---|---|---|
| 财富管理 | ¥6.36B | 33.0% |
| 股票业务 | ¥5.29B | 27.4% |
| 投资银行 | ¥3.38B | 17.5% |
| 固定收益 | ¥1.95B | 10.1% |
| 私募股权 | ¥0.87B | 4.5% |
| 其他 | ¥0.78B | 4.0% |
| 资产管理 | ¥0.67B | 3.5% |
| Item | Amount | % of revenue |
|---|---|---|
| SG&A | ¥8.82B | 45.7% |
| Tax & other | ¥1.94B | 10.1% |
| Item | Amount |
|---|---|
| Total assets | ¥997.15B |
| Total liabilities | ¥854.78B |
| Shareholders' equity | ¥142.37B |
| Equity / assets | 14.3% |
| Operating cash flow | ¥37.71B |
| Capital expenditure | ¥0.12B |
| Free cash flow | ¥37.59B |
| Cash conversion (OCF / net income) | 770% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
中信银行 ・ 中科曙光 ・ 药明康德 ・ 合盛硅业 ・ 海天味业 ・ 华勤技术 ・ 今世缘 ・ 万泰生物 ・ 豪威集团 ・ 华友钴业 ・ 瑞芯微 ・ 兆易创新
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies